Main Article Content
This article studies the therapeutic effect and nursing experience of octreotide in treating hypoglycemia in acute pancreatitis. Method: Sixty patients with acute pancreatitis treated in our hospital from January 2019 to February 2020 were selected as the study subjects, and the patients who met the criteria were randomly divided into intervention group (n=30) and control group (n=30).Both groups of patients were treated with octreotide, while the intervention group was given personalized whole-course intervention on the basis of it, to compare the treatment effect of the two groups and the occurrence of hypoglycemia. Results: The total effective rate was 73.33% in the control group and 96.67% in the intervention group. There was a significant difference in data between the intervention group and the control group (P < 0.05). The incidence of hypoglycemia was 26.67% in the control group and 3.33% in the intervention group. The difference between the control group and the intervention group was statistically significant (P < 0.05). The incidence of adverse reactions was 36.67% in the control group and 6.67% in the intervention group. The difference between the control group and the intervention group was statistically significant (P < 0.05). The nursing satisfaction of the patients in the control group was 79.00%, and that of the intervention group was 96.67%. The difference between the intervention group and the control group was statistically significant (P < 0.05). Conclusion: Octreotide has a good effect in the treatment of patients with acute pancreatitis. If personalized whole-course intervention can be given to patients with acute pancreatitis who receive 24-hour octreotide pump drip, the treatment effect, nursing satisfaction, adverse reactions and hypoglycemia can be further improved, and the patient's condition can be effectively maintained stable and the patient can recover as soon as possible.